Cardio-Vascular
Show
- Cholesterol
- Lowering Lipoprotein(a) Cholesterol with Natural Therapies: A Clinic Study
- Heart diseases, particularly coronary heart disease (CHD), remain the #1 risk of disability and death in western countries in both men and women.
- 1586 0
- Stroke
- How Algernon Pharmaceuticals is aiming to use psychedelics to aid stroke recover
- Should Algernon’s trials succeed and it’s able to break barriers for therapeutic uses of psychedelics such as DMT, the potential number of patients is massive.
- 478 0
- Clinical Research Abstracts
- Top Cardiology and Nutrition Research of 2020: A Plant Slant
- Nine of the top medical stories in 2020, other than the global outbreak, that are worth emphasizing
- 363 0
- Sleep
- The science of siestas: New research reveals the genetic basis for daytime napping
- “This tells us that daytime napping is biologically driven and not just an environmental or behavioral choice,”
- 1552 0
-
- Cholesterol
- Lowering Lipoprotein(a) Cholesterol with Natural Therapies: A Clinic Study
- Heart diseases, particularly coronary heart disease (CHD), remain the #1 risk of disability and death in western countries in both men and women.
- 1586 0
-
- Stroke
- How Algernon Pharmaceuticals is aiming to use psychedelics to aid stroke recover
- Should Algernon’s trials succeed and it’s able to break barriers for therapeutic uses of psychedelics such as DMT, the potential number of patients is massive.
- 478 0
-
- Clinical Research Abstracts
- Top Cardiology and Nutrition Research of 2020: A Plant Slant
- Nine of the top medical stories in 2020, other than the global outbreak, that are worth emphasizing
- 363 0
-
- Sleep
- The science of siestas: New research reveals the genetic basis for daytime napping
- “This tells us that daytime napping is biologically driven and not just an environmental or behavioral choice,”
- 1552 0
Load More
